Senior insider sale
President and CBO at POSEIDA THERAPEUTICS, INC. — senior position signals high conviction
$343.2K
120K shares
What this filing means
GERGEN MARK J plans to sell 120K shares of POSEIDA THERAPEUTICS, INC. valued at approximately $343.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/26/2024ACC: 0001950047-24-009144
DirectorOfficer· President and CBO
Since Jul 2020
120K
Shares to sell
$343.2K
Approx. market value
120K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
11/26/2024
120KTotal acquired120K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/26/2024 | Exercise of Stock Options Cash | 120K | — |
| Total | 120K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
120K
Market value
$343.2K
11/26/2024
Total
Units
120K
Value
$343.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/26/2024 | 120K | $343.2K | NASDAQ | Planned |
| Total | 120K | $343.2K | ||